Pinaki Biswas

4PUBLICATIONS
25CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersAllergyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 07, 2026
Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL.

|May 20, 2026
Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.

|Sep 23, 2025
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?

Eric L Simpson, Jonathan I Silverberg, Bob Geng

|Feb 04, 2025
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE.

Jonathan I Silverberg, Eric L Simpson, Andrew E Pink

Pageof 1

Frequent Collaborators

3 joint publications

Jonathan I Silverberg

3 joint publications

Eric L Simpson

2 joint publications

Stephan Weidinger

2 joint publications

Herwig Koppensteiner